Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 8 Anti-inflammatory cytokines

From: Effects of powdered Montmorency tart cherry supplementation on acute endurance exercise performance in aerobically trained individuals

Variable

Group

Baseline

Pre-Run

60-min Post

24-hr Post

48-hr Post

Group Mean

p-value (GG)

p-value (WSC)

RFT Covariate p-value (WSC)

IL-4 (pg/mL)

P

4.57 ± 2.02

5.51 ± 2.31

5.20 ± 2.15

4.02 ± 1.49

4.21 ± 1.63

4.70 ± 1.28

G = 0.304

 

G = 0.165

TC

6.93 ± 8.98

8.71 ± 11.72

6.65 ± 6.37

5.41 ± 5.13

6.38 ± 7.03

6.82 ± 1.55

T = 0.012*

T q   = 0.012*

T L   = 0.309

Time Mean

5.53 ± 5.89

6.82 ± 7.64

5.79 ± 4.34

4.59 ± 3.45Ψ◊

5.09 ± 4.66Ψ◊#

 

G X T = 0.320

G X T q   = 0.189

G X T L   = 0.189

IL-5 (pg/mL)

P

0.57 ± 0.37

0.63 ± 0.42

0.66 ± 0.47

0.66 ± 0.46

0.61 ± 0.40

0.62 ± 0.14

G = 0.102§

 

G = 0.013*

TC

0.96 ± 0.75

1.01 ± 0.73

1.07 ± 0.76

1.01 ± 0.80

0.87 ± 0.59

0.98 ± 0.16

T = 0.093§

T q   = 0.013*

T q   = 0.452

Time Mean

0.73 ± 0.58

0.78 ± 0.59

0.82 ± 0.62

0.80 ± 0.63

0.71 ± 0.49Ψ◊#

 

G X T = 0.542

G X T L   = 0.185

G X T L   = 0.205

IL-7 (pg/mL)

P

3.75 ± 1.63

3.37 ± 1.57

4.66 ± 2.61

3.72 ± 1.81

3.47 ± 1.15

3.80 ± 0.43

G = 0.295

 

G = 0.427

TC

4.66 ± 2.54

4.27 ± 1.84

5.12 ± 2.22

4.55 ± 1.69

4.01 ± 1.42

4.52 ± 0.52

T <0.001*

T q   = 0.010*

T L   = 0.845

Time Mean

4.12 ± 2.06

3.74 ± 1.71†

4.85 ± 2.42†Ψ

4.06 ± 1.78◊

3.69 ± 1.27◊#

 

G X T = 0.708

G X T L   = 0.492

G X T L   = 0.485

IL-10 (pg/mL)

P

2.91 ± 3.13

2.77 ± 1.89

24.17 ± 26.99

2.77 ± 1.78

2.68 ± 1.68

7.06 ± 1.36

G = 0.683

 

G = 0.948

TC

3.31 ± 2.74

3.99 ± 5.07

17.16 ± 18.60

3.66 ± 3.69

2.79 ± 1.98

6.18 ± 1.64

T = 0.001*

T q   = 0.001*

T q   = 0.691

Time Mean

3.07 ± 2.93

3.27 ± 3.51

21.31 ± 23.79†Ψ

3.13 ± 2.70◊

2.72 ± 1.77◊

 

G X T = 0.421

G X T q   = 0.495

G X T L   = 0.509

IL-13 (pg/mL)

P

1.52 ± 0.95

1.77 ± 1.14

1.86 ± 1.27

1.55 ± 1.00

1.58 ± 0.86

1.65 ± 0.36

G = 0.091§

 

G = 0.031*

TC

2.56 ± 2.01

2.96 ± 2.37

2.74 ± 1.75

2.56 ± 2.00

2.40 ± 1.66

2.65 ± 0.43

T = 0.006*

T q   = 0.003*

T q   = 0.027*

Time Mean

1.94 ± 1.53

2.25 ± 1.80†

2.22 ± 1.52†

1.96 ± 1.54Ψ◊

1.91 ± 1.29Ψ◊

 

G X T = 0.538

G X T L   = 0.236

G X T q   = 0.053§

  1. Individual group and time data expressed as means ± SD, while group effects are presented as means ± SEM. Data represents the anti-inflammatory response at each testing session during the 10 day intervention. MANOVA analysis revealed overall Wilks’ Lambda time (p <0.001) and group x time (p = 0.447). Univariate ANOVA p-levels from MANOVA analysis are presented for each variable. Univariate ANOVA p-levels are listed first by the Greenhouse-Geisser (GG) analysis and then by the within-subjects contrasts (WSC) to demonstrate the potential shape of the time or group x time interaction with significance indicated by the following super/subscripts: * indicates p <0.05 p-level significance, § indicates p <0.10 p-level significance. LSD post hoc analysis is indicated by the following superscripts: † represents p <0.05 difference from baseline value, Ψ represents p <0.05 difference from pre-run, ◊ represents p <0.05 difference from 60-min post, # represents p <0.05 difference from 24-hr post. IL interleukin, RFT race finish time, G group p-level, T time p-level, G x T interaction; q quadratic p-level, L linear p-level
Back to article page

Journal of the International Society of Sports Nutrition

ISSN: 1550-2783

Contact us